相关实验视频
Updated: Sep 11, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.8K
在心脏护理试验中,人环素剂量,心肌损伤和左心室功能变化
Krithika Loganath1, Kuan Ken Lee2, Olga Oikonomidou3
1BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
JACC. CardioOncology
|August 14, 2025
概括
高灵敏性心脏托罗邦素I (hs-cTnI) 水平没有预测在安赛克林化疗后左心室喷射分数的下降. 通过hs-cTnI表示的轻度心肌损伤可能无法可靠地预测癌症幸存者的随后心脏功能障碍.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 心脏瘤学 - 心脏瘤学
背景情况:
- 在癌症幸存者中,抗环素化疗可能会导致长期心血管损伤.
- 心脏热素用于风险分层,但其与心脏功能障碍的关联不清楚,特别是高灵敏度测试.
研究的目的:
- 为了研究高灵敏性心脏素I (hs-cTnI),环素剂量和左心室 (LV) 功能变化之间的关系.
- 为了评估hs-cTnI是否可以预测心脏功能障碍后的Anthracycline治疗.
主要方法:
- 对接受抗环素化疗的患者进行前性研究,基线hs-cTnI升高.
- 序列测量Hs-cTnI;在基线和化疗后6个月,通过心脏磁共振评估LV功能.
主要成果:
- Hs-cTnI与治疗周期相关,但不是累积的环素剂量.
- 一小部分患者 (14.0%) 经历了LV射出分数 (LVEF) >10%的下降.
- Hs-cTnI与LVEF变化呈现较弱的相关性,并预测了全球纵向应变.
结论:
- Hs-cTnI水平与累积的环素剂量或显著的LVEF下降没有显著的关联.
- 轻度心肌损伤,以hs-cTnI为标志,可能不是继安赛克林化疗后心脏功能障碍的可靠预测指标.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiac Catheterization I: Pre-Procedure Overview
153
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
153
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Exercise and Cardiovascular Response
1.1K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Myocarditis III: Medical Management
16
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16

